The US Food and Drug Administration (FDA) has granted accelerated approval to pirtobrutinib (Jaypirca; Eli Lilly and Company) for third-line or later treatment in adults with chronic lymphocytic ...
Findings showed pirtobrutinib was noninferior to ibrutinib in both the pre-treated and intent-to-treat populations for the endpoint of ORR. Topline data were announced from a head-to-head phase 3 ...
Korean production and distribution company SLL is riding high on the current box office success of “The Roundup: No Way Out,” the only local film this year to sell more than 10 million tickets. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results